COVISHIELD | Zee News

Advertisement

COVISHIELD News

08 May 2024

Covishield Maker AstraZeneca Withdraws Covid-19 Vaccine Globally

According to AstraZeneca, the vaccination has been replaced by revised shots that address novel variations.

30 Apr 2024

DNA: AstraZeneca's Covid vaccine may cause blood clotting

Thrombosis with Thrombocytopenia Syndrome

30 Apr 2024

AstraZeneca's Covishield Vaccine Can Lead To Blood Clots: Know All About TTS

TTS is thrombosis with thrombocytopenia syndrome, which is a clot in blood vessels of the brain or elsewhere, along with a low platelet count TTS has emerged as a rare but significant concern associated with the AstraZeneca Covid-19 vaccine A doctor, however, emphasised that these findings don't change the fact that the vaccines were essential to fight COVID-19

03 Sep 2022

Man demands Rs 1,000 crore from Covid-19 vaccine makers for daughter's death

A man has filed a petition seeking a response from the makers of Covishield claiming that the vaccine caused his daughter's death He has demanded a compensation of Rs 1,000 crore from the Indian-vaccine maker Serum Institute of India (SII)

10 Aug 2022

Corbevax cleared as Covid booster dose for Covaxin, Covishield recipients

Govt clears Corbevax as Covid-19 booster dose for adults vaccinated with Covaxin, Covishield Health Ministry's approval is based on the recommendations made by the NTG Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the COVID-19 immunisation programme.

04 Jun 2022

CORBEVAX becomes first vaccine in India to get approval for COVID booster dose

CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose. People who are 18 years & above & have already taken two doses of either COVISHIELD or COVAXIN can now receive a dose of CORBEVAX. The vaccine can be taken after 6 months of two doses of Covaxin or Covishield vaccines for restricted use in emergency situation.

02 Jun 2022

Monkeypox cases due to the side effect of Covid-19 vaccine? Answer here

Monkeypox outbreak: Social media posts claiming the chimpanzee adenovirus vector used in AstraZeneca's Covid vaccine, causes Monkeypox have surfaces, PTI reported.

07 May 2022

Sputnik booster dose approved in India, over 6.5 lakh people eligible: Report

Sputnik booster dose has been approved in India. Over 6.5 lakh people who have received Sputnik vaccine will be eligible to take the booster dose. India had earlier approved a third dose of COVID vaccines – Covaxin and Covishield – for adults.

30 Apr 2022

Several vials of Covid vaccine found in garbage dump in UP’s Kannauj

Several vials of Covid vaccine found in a garbage dump in UP. A probe has been ordered in this regard. A vial of Covishield is opened only when 10 patients are available to take the dose.

08 Apr 2022

No more free of cost, Serum finalises the price of Covishield Booster dose

Government have decided to allow Coronavirus booster shots to all adults from Sunday The third jab will not be free for most adults Mr Poonawala said that Serum Institute will offer large discounts to hospitals and distributors

04 Apr 2022

Fourth wave of Covid-19 to hit India? Here's what SII CEO Adar Poonawalla says

Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right vaccine.

Covid-19 fourth wave

21 Mar 2022

Amid fourth wave scare, expert body suggests reducing gap b/w Covishield doses

India's apex body on immunisation NTAGI has recommended administering the second dose of Covishield between eight and 16 weeks after the first dose.

20 Mar 2022

Reduce Covishield dose gap to 8-16 weeks, recommends panel

The National Technical Advisory Group on Immunisation has recommended reducing the Covishield dose gap. Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose. India continues on a downward trend of new Covid cases.

COVID-19 vaccine

03 Feb 2022

Misleading: Centre on reports claiming 50L unused Covishield jabs may go waste

Health ministry has denied Covishield doses going to waste reports. The health ministry said states were advised that no vaccine dose gets expired.

26 Jan 2022

Covishield, Covaxin likely to be capped at Rs 275 after regular market nod

Covaxin and Covishield were granted Emergency Use Authorisation (EUA) on January 3 last year Serum Institue of India had submitted application to DCGI seeking regular market approval for Covishiled

20 Jan 2022

Govt panel recommends regular market approval for Covishield, Covaxin

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said.

COVID-19 vaccine

04 Jan 2022

Is mixing and matching Covishield, Covaxin safe? Study provides BIG update

A total of 330 volunteers, who were not vaccinated and had no history of the COVID-19 infection, were selected and screened for SARS-CoV-2 antibodies for the study.

23 Dec 2021

Lancet study about Covishield 3 months efficacy misquoted, say experts

Scientific data available says that vaccines provide antibodies, said Dr JA Jayala It will be preventing you and helping you to come out of the severe infection, said Jayala

10 Dec 2021

Covishield booster: Subject Expert panel to meet today to discuss approval

The SII has recently filed an application with the DCGI regarding approval for a booster dose of Covishield It cited that there is adequate stock of the Covid vaccine in the country A demand for a booster shot is there due to the emergence of new coronavirus variants

Serum Institute of India

01 Dec 2021

Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose

SII cited adequate stock of the vaccine in the country and a demand for a booster.

Loading...

NEWS ON ONE CLICK